Robert J Pelley, MD in Cleveland, OH - Internal Medicine

Robert J Pelley, MD is a Internal Medicine - Hematology & Oncology physician based in Cleveland, Ohio. Robert J Pelley is licensed to practice in Ohio (license number 35047677P) and his current practice location is 9500 Euclid Ave, Cleveland, Ohio. He can be reached at his office (for appointments etc.) via phone at (800) 223-2273.

NPI number for Robert J Pelley is 1346205002 and his current mailing address is 6000 W Creek Rd, Suite 10, Independence, Ohio. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1346205002.

Contact Information

	Robert J Pelley, MD
	9500 Euclid Ave, Cleveland, OH 44195-0001
	(800) 223-2273
	Not Available

Physician's Profile

Full Name	Robert J Pelley
Gender	Male
Speciality	Internal Medicine - Hematology & Oncology
Location	9500 Euclid Ave, Cleveland, Ohio
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1346205002
Provider Enumeration Date: 04/18/2006
Last Update Date: 02/11/2008

Medical Identifiers

Medical identifiers for Robert J Pelley such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1346205002	NPI	-	NPPES
0673098	Medicaid	OH

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RH0003X	Internal Medicine - Hematology & Oncology	35047677P (Ohio)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Robert J Pelley is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Robert J Pelley, MD 6000 W Creek Rd, Suite 10, Independence, OH 44131-2139 Ph: (800) 223-2273	Robert J Pelley, MD 9500 Euclid Ave, Cleveland, OH 44195-0001 Ph: (800) 223-2273

News Archive

Trubion Pharmaceuticals to present promising data from Phase 1 studies of SBI-087, SBI-087

Trubion Pharmaceuticals, Inc. today announced the acceptance of two Phase 1 data presentations on SBI-087 (PF-05230895) at the 2010 annual congress of the European League Against Rheumatism (EULAR) in Rome, Italy. Presentations will include promising data from a Phase 1 study of SBI-087 for the treatment of rheumatoid arthritis (RA) and a Phase 1 study of SBI-087 for the treatment of systemic lupus erythematosus (SLE). Copies of both abstracts are available at http://www.eular.org. SBI-087 is Trubion's next-generation CD20-directed small modular immunopharmaceutical (SMIP™) product candidate and is being developed in collaboration with Pfizer.

Watson commences Esmya Phase 3 trial in women with anemia linked to uterine leiomyomas

Watson Pharmaceuticals, Inc. today announced it has initiated its Phase 3 trial to evaluate the efficacy and safety of Esmya (ulipristal acetate) in women with anemia associated with uterine leiomyomas, a medical condition often referred to as uterine fibroids (myomas). Leiomyomata are benign solid tumors that often lead to excessive menstrual bleeding, anemia and pain, which ultimately may require surgical intervention.

Seafood provides essential nutrients but consumers still keep watchful eye on safety

Seafood continues to be a proven strong nutrient-rich food providing essential vitamins, minerals and omega-3 fatty acids, but consumers and some toxicologists still keep a watchful eye on safety, according to a July 16 panel discussion at the 2013 Institute of Food Technologists (IFT) Annual Meeting & Food Expo- held at McCormick Place.

University of Texas launches phase II clinical trial to test stem-cell-based therapy on injured heart muscle

The second phase of a clinical trial testing a new stem-cell-based therapy on injured heart muscle has been launched by researchers at The University of Texas Medical School at Houston. It is the only study site in the Texas Medical Center.

Monocytic tRNA fragments play key role in poststroke immune reactions

Sebastian Lobentanzer of Goethe University, Frankfurt, has been studying small RNA dynamics in various contexts using bioinformatic methods. Recently, small RNAs have become more and more interesting for researchers, primarily because of their extensive regulatory functions.

Internal Medicine Doctors in Cleveland, OH

Amir Razavi, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-7800
Dr. Francois Fadell, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 18200 Lorain Ave, Moll Cancer Center At Fairview- Respiratory Institute, Cleveland, OH 44111 Phone: 216-444-6503
Sana Hasan, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 Phone: 330-721-5700
Catherine Frakes Vozzo, DO Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 216-444-4444 Fax: 216-445-6290
Tarek Ashour, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave # Q7, Cleveland, OH 44195 Phone: 216-444-5040
Mrs. Efewongbe Benedicta Oleghe, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2351 E 22nd Street, St Vincent's Charity Medical Center, Cleveland, OH 44115 Phone: 216-363-2725
Dr. Toufik Z. Madhun, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 11100 Euclid Ave Dept Of, Cleveland, OH 44106 Phone: 216-844-1000

Robert J Pelley, MD - Internal Medicine in Cleveland, OH